Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2010

Open Access 01-12-2010 | Case report

Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature

Authors: Tomoki Yamano, Eiichi Morii, Isao Arai, Toshiaki Takada, Katsuyuki Aozasa

Published in: Journal of Medical Case Reports | Issue 1/2010

Login to get access

Abstract

Introduction

Small bowel adenocarcinoma is a rare malignancy associated with a poor prognosis and there is little evidence of effective treatment. Recurrent small bowel adenocarcinoma is an intractable disease for which there is little information available regarding its treatment by palliative therapy. We present a case of recurrent small bowel adenocarcinoma successfully treated by cytoreductive surgery and palliative chemotherapy.

Case presentation

We report the case of a 72-year-old Japanese female who developed a peritoneal metastasis from recurrent small bowel adenocarcinoma after curative resection and adjuvant chemotherapy with S-1 and polysaccharide K. She underwent cytoreductive surgery followed by chemotherapy with folinic acid/fluorouracil/oxaliplatin and folinic acid/fluorouracil/irinotecan with polysaccharide K. Subsequently, no sign of a recurrence was observed 42 months after the second operation.

Conclusion

To the best of our knowledge, this is the first case report of the successful treatment of peritoneal metastasis from small bowel adenocarcinoma by cytoreductive surgery and combination chemotherapy (folinic acid/fluorouracil/oxaliplatin and folinic acid/fluorouracil/irinotecan with polysaccharide K).
Appendix
Available only for authorised users
Literature
1.
go back to reference Martin RG: Malignant tumors of the small intestine. Surg Clin North Am. 1986, 66: 779-785.PubMed Martin RG: Malignant tumors of the small intestine. Surg Clin North Am. 1986, 66: 779-785.PubMed
2.
go back to reference Howe JR, Karnell LH, Menck HR, Scott-Conner C: Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999, 86: 2693-2706. 10.1002/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U.CrossRefPubMed Howe JR, Karnell LH, Menck HR, Scott-Conner C: Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999, 86: 2693-2706. 10.1002/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U.CrossRefPubMed
3.
go back to reference Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J: Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004, 101: 518-526. 10.1002/cncr.20404.CrossRefPubMed Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J: Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004, 101: 518-526. 10.1002/cncr.20404.CrossRefPubMed
4.
go back to reference Singhal N, Singhal D: Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev. 2007, 3: CD005202-PubMed Singhal N, Singhal D: Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev. 2007, 3: CD005202-PubMed
5.
go back to reference Overman MJ: Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res. 2009, 3: 90-96.PubMedPubMedCentral Overman MJ: Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res. 2009, 3: 90-96.PubMedPubMedCentral
6.
go back to reference Gibson MK, Holcroft CA, Kvols LK, Haller D: Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist. 2005, 10: 132-137. 10.1634/theoncologist.10-2-132.CrossRefPubMed Gibson MK, Holcroft CA, Kvols LK, Haller D: Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist. 2005, 10: 132-137. 10.1634/theoncologist.10-2-132.CrossRefPubMed
7.
go back to reference Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS, Eng C, Abbruzzese JL, Wolff RA: Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009, 27: 2598-2603. 10.1200/JCO.2008.19.7145.CrossRefPubMed Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS, Eng C, Abbruzzese JL, Wolff RA: Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009, 27: 2598-2603. 10.1200/JCO.2008.19.7145.CrossRefPubMed
8.
go back to reference Fishman PN, Pond GR, Moore MJ, Oza A, Burkes RL, Siu LL, Feld R, Gallinger S, Greig P, Knox JJ: Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol. 2006, 29: 225-231. 10.1097/01. coc.0000214931.01062.01.CrossRefPubMed Fishman PN, Pond GR, Moore MJ, Oza A, Burkes RL, Siu LL, Feld R, Gallinger S, Greig P, Knox JJ: Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol. 2006, 29: 225-231. 10.1097/01. coc.0000214931.01062.01.CrossRefPubMed
9.
go back to reference Marchettini P, Sugarbaker PH: Mucinous adenocarcinoma of the small bowel with peritoneal seeding. Eur J Surg Oncol. 2002, 28: 19-23. 10.1053/ejso.2001.1196.CrossRefPubMed Marchettini P, Sugarbaker PH: Mucinous adenocarcinoma of the small bowel with peritoneal seeding. Eur J Surg Oncol. 2002, 28: 19-23. 10.1053/ejso.2001.1196.CrossRefPubMed
10.
go back to reference Jacks SP, Hundley JC, Shen P, Russell GB, Levine EA: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma. J Surg Oncol. 2005, 91: 112-117. 10.1002/jso.20296.CrossRefPubMed Jacks SP, Hundley JC, Shen P, Russell GB, Levine EA: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma. J Surg Oncol. 2005, 91: 112-117. 10.1002/jso.20296.CrossRefPubMed
11.
go back to reference Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H: ACTS-GC Group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007, 357: 1810-1820. 10.1056/NEJMoa072252.CrossRefPubMed Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H: ACTS-GC Group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007, 357: 1810-1820. 10.1056/NEJMoa072252.CrossRefPubMed
12.
go back to reference Sakamoto J, Morita S, Oba K, Matsui T, Kobayashi M, Nakazato H, Ohashi Y, Meta-Analysis Group of the Japanese Society for Cancer of the Colon Rectum: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother. 2006, 55: 404-411. 10.1007/s00262-005-0054-1.CrossRefPubMed Sakamoto J, Morita S, Oba K, Matsui T, Kobayashi M, Nakazato H, Ohashi Y, Meta-Analysis Group of the Japanese Society for Cancer of the Colon Rectum: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother. 2006, 55: 404-411. 10.1007/s00262-005-0054-1.CrossRefPubMed
13.
go back to reference Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother. 2007, 56: 905-911. 10.1007/s00262-006-0248-1.CrossRefPubMed Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J: Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother. 2007, 56: 905-911. 10.1007/s00262-006-0248-1.CrossRefPubMed
14.
go back to reference Chen ZM, Wang HL: Alteration of cytokeratin 7 and cytokeratin 20 expression profiles is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol. 2004, 28: 1352-1359. 10.1097/01.pas.0000135520.72965.50.CrossRefPubMed Chen ZM, Wang HL: Alteration of cytokeratin 7 and cytokeratin 20 expression profiles is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol. 2004, 28: 1352-1359. 10.1097/01.pas.0000135520.72965.50.CrossRefPubMed
15.
go back to reference Overman MJ, Kopetz S, Wen S, Hoff PM, Fogelman D, Morris J, Abbruzzese JL, Ajani JA, Wolff RA: Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer. 2008, 113: 2038-2045. 10.1002/cncr.23822.CrossRefPubMed Overman MJ, Kopetz S, Wen S, Hoff PM, Fogelman D, Morris J, Abbruzzese JL, Ajani JA, Wolff RA: Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer. 2008, 113: 2038-2045. 10.1002/cncr.23822.CrossRefPubMed
16.
go back to reference Locher C, Malka D, Boige V, Lebray P, Elias D, Lasser P, Ducreux M: Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology. 2005, 69: 290-294. 10.1159/000089678.CrossRefPubMed Locher C, Malka D, Boige V, Lebray P, Elias D, Lasser P, Ducreux M: Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology. 2005, 69: 290-294. 10.1159/000089678.CrossRefPubMed
17.
go back to reference Polyzos A, Kouraklis G, Giannopoulos A, Bramis J, Delladetsima JK, Sfikakis PP: Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother. 2003, 15: 503-506.CrossRefPubMed Polyzos A, Kouraklis G, Giannopoulos A, Bramis J, Delladetsima JK, Sfikakis PP: Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother. 2003, 15: 503-506.CrossRefPubMed
18.
go back to reference Dasari BV, Gardiner KR: Management of adenocarcinoma of the small intestine. Gastrointest Cancer Res. 2009, 3: 121-122.PubMedPubMedCentral Dasari BV, Gardiner KR: Management of adenocarcinoma of the small intestine. Gastrointest Cancer Res. 2009, 3: 121-122.PubMedPubMedCentral
19.
go back to reference Levine EA, Stewart JH, Russell GB, Geisinger KR, Loggie BL, Shen P: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007, 204: 943-53. 10.1016/j.jamcollsurg.2006.12.048.CrossRefPubMed Levine EA, Stewart JH, Russell GB, Geisinger KR, Loggie BL, Shen P: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007, 204: 943-53. 10.1016/j.jamcollsurg.2006.12.048.CrossRefPubMed
Metadata
Title
Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature
Authors
Tomoki Yamano
Eiichi Morii
Isao Arai
Toshiaki Takada
Katsuyuki Aozasa
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2010
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-4-213

Other articles of this Issue 1/2010

Journal of Medical Case Reports 1/2010 Go to the issue